Answers are grounded in this paper and cite their sources.
People are widely exposed to the antimicrobial cetylpyridinium chloride (CPC) via consumer products, but CPC is a mitochondrial toxicant with potency comparable to that of canonical mitotoxicants. CPC is largely unregulated despite growing usage, bioavailability, and ability to cross the blood-brain barrier. Previously, we showed, in several cell types at non-cytotoxic and exposure-relevant doses, CPC inhibits ATP and oxygen consumption rate. Mitochondrial toxicity is linked to multiple diseases, but CPC has not been studied epidemiologically, and its mode of action is unknown. To determine why oxygen consumption is hampered by CPC, we hypothesized that CPC inhibits electron transport chain components, cardiolipin, or Krebs cycle enzymes. Here, we show that, in primary human skin cells, an immune mast cell model, and isolated mitochondria, CPC apparently inhibits multiple electron transport chain Complexes. Detailed investigation pinpointed the mechanism to the distal end of electron transport chain: Complex III-cytochrome c-Complex IV. Using multiple approaches, we show that CPC does not directly inhibit any of the Complexes, nor Krebs enzymes, nor coenzyme Q. Yet, CPC exhibits mitotoxicity with potency comparable to cyanide. In healthy mitochondria, the lipid cardiolipin attracts cytochrome c so that it may shuttle electrons from Complex III to IV. We present evidence implicating electrostatic CPC interference in cardiolipin-cytochrome c interactions. To provide data for focusing epidemiological investigations, clarifying risk analysis, and positing new mechanisms of action for predictive toxicology, we determined the biochemical mechanism of action of this ubiquitous chemical, a model for the large class of quaternary ammonium compounds.
No takes yet. Share an insight, caveat, or question.
Ledue et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: